Hematological and biochemical parameters in SARS-CoV-2 infection in patients attended to at the Jipijapa health center
DOI:
https://doi.org/10.62305/biosana.v4i5.352Keywords:
COVID-19; biomarcadores; leucocitosis; inflamaciónAbstract
COVID-19 disease is caused by SARS-CoV-2, a pathogenic and highly transmissible single-stranded RNA virus. It rapidly went from an epidemic to a worldwide pandemic spreading at alarming levels. SARS-CoV-2 infection significantly affects the respiratory system, but can involve other systems, including the hematopoietic system and homeostasis, as well as causing various alterations in hematological and biochemical parameters. The general objective of this study was to identify variations in hematological and biochemical parameters in SARS-CoV-2 infection in patients treated at the Jipijapa Health Center. The methodology was based on a cross-sectional descriptive design, using a sample of 306 patients diagnosed with SARS-CoV-2. The results showed hematological alterations such as low hemoglobin levels, leukocytosis, lymphopenia, neutrophilia and thrombocytopenia; in the biochemical parameters, alterations in glucose and liver enzymes were observed. LDH and CRP also presented values above the normal range. These variations were more significant in the group of patients positive for SARS-CoV-2 (p<0.05). In conclusion, the results of this study highlight the importance of monitoring these parameters in patients infected by this virus, since they can be considered as indicators of disease progression and severity.
Downloads
References
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med [Internet]. 2020 Feb;382(8):727–33. Available from: https://doi.org/10.1056/nejmoa2001017
Organización Mundial de la Salud(OMS). Enfermedad por coronavirus (COVID-19) [Internet]. 2023. Available from: https://www.who.int/es/news-room/fact-sheets/detail/coronavirus-disease-(covid-19)
Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH. Extrapulmonary complications of COVID-19: A multisystem disease? J Med Virol [Internet]. 2021 Jan;93(1):323–35. Available from: https://doi.org/10.1002/jmv.26294
Mousavi SA, Rad S, Rostami T, Rostami M, Mousavi SA, Mirhoseini SA, et al. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology [Internet]. 2020 Dec;25(1):383–8. Available from: https://doi.org/10.1080/16078454.2020.1833435
Ciaccio M, Agnello L. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis (Berlin, Ger [Internet]. 2020;7(4):365–72. Available from: http://europepmc.org/abstract/MED/32589600
Gutovitz S, Hanson J, Vandever C, Jehle D. Clinical Characteristics and Laboratory Biomarkers for Patients with Suspected COVID-19 Infection Within HCA Healthcare. HCA Healthc J Med [Internet]. 2021;2(3):229–36. Available from: https://doi.org/10.36518/2689-0216.1233
Urbano M, Costa E, Geraldes C. Hematological changes in SARS-COV-2 positive patients. Hematol Transfus Cell Ther [Internet]. 2022;44(2):218–24. Available from: https://www.sciencedirect.com/science/article/pii/S2531137922000128
Anzules Guerra JB, Véliz Zevallos IJ, Loor Vélez KE, Sánchez Rodríguez JM, Delgado Saldarriaga LM, Alcívar Cedeño LM, et al. Parámetros bioquímicos y biometría hemática de pacientes con COVID-19 moderado y grave en terapia intensiva de un hospital básico de Ecuador. Boletín Malariol y Salud Ambient [Internet]. 2022;62(5):1005–17. Available from: https://docs.bvsalud.org/biblioref/2023/04/1427043/590-1728-2-pb.pdf
Paredes De La Fuente R, Contreras Chavez P, Jordan Bruno X, Cornejo R, Sanchez-Jacinto B, Estrada S, et al. Characterizing Hematological Changes and Morphological Abnormalities in Hospitalized COVID-19 Patients of Hispanic Descent. Blood [Internet]. 2023 Nov 2;142(Supplement 1):5609. Available from: https://doi.org/10.1182/blood-2023-185016
Albarrán-Sánchez A, González-Ríos RD, Alberti-Minutti P, Noyola-García ME, Contreras-García CE, Anda-Garay JC, et al. Association of neutrophil-to-lymphocyte and lymphocyte-to-c-reactive protein ratios with covid-19-related mortality. Gac Med Mex [Internet]. 2020;156(6):563–8. Available from: https://doi.org/10.24875/gmm.m21000481
Kosmeri C, Koumpis E, Tsabouri S, Siomou E, Makis A. Hematological manifestations of SARS-CoV-2 in children. Pediatr Blood Cancer. 2020 Dec;67(12):e28745.
Gholizadeh P, Safari R, Marofi P, Zeinalzadeh E, Pagliano P, Ganbarov K, et al. Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19). J Inflamm Res [Internet]. 2020 Jul 1;13(null):285–92. Available from: https://www.tandfonline.com/doi/abs/10.2147/JIR.S257078
Marín-Dueñas I, Vega J, Carrillo-Ng H, Veramendi-Schult I, Zavaleta-Alva R, Vásquez-Elera L, et al. Alteration in liver function tests among patients hospitalized for COVID-19: a multicentric study in Peru. Rev Gastroenterol Peru [Internet]. 2021 Jun 30 [cited 2022 Aug 15];41(2):86–93. Available from: http://www.revistagastroperu.com/index.php/rgp/article/view/1284
Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, et al. A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias. Clin Infect Dis [Internet]. 2020 Jul 28;71(15):756–61. Available from: https://doi.org/10.1093/cid/ciaa247
Ahmed S, Mohammed D, Mohammed A. Hematological Parameters in Adult Patients with COVID-19; A Case-Control Study. Int J Infect [Internet]. 2021;8(4):e110359. Available from: https://brieflands.com/articles/iji-110359
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 BIOSANA Health Scientific Journal. ISSN 2960-8481
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
